
Peptides et Protéines
3151 produits trouvés pour "Peptides et Protéines"
Cyclosporin H
CAS :Applications Cyclosporin is an immunosuppressant that has revolutionized organ transplantation through its use in the prevention of graft rejection.A group of nonpolar cyclic oligopeptides with immunosupppressant activity.
References van Wartburg, A., et al.: Prog. Med. Chem., 25, 1 (1988), Jorgensen, K.A., et al.: Scand. J. Imunol., 57, 93 (2003), Vollenbroeker, et al.: Transplant. Proc., 37, 1741 (2005),Formule :C62H111N11O12Couleur et forme :NeatMasse moléculaire :1202.61N-Acetyl-DL-methionine
CAS :Produit contrôléApplications C7H13NO3S (cas# 1115-47-5) is a useful research chemical.
Formule :C7H13NO3SCouleur et forme :NeatMasse moléculaire :191.25DL-Methionyl-DL-methionine
CAS :Produit contrôléFormule :C10H20N2O3S2Couleur et forme :NeatMasse moléculaire :280.4N-Acetyl-L-methionine
CAS :Produit contrôléApplications N-Acetyl-L-methionine (CAS# 65-82-7) has been useful in the study of metabolic phenotypes of standard and cold-stored platelets.
References D’Alessandro, A., et al.: Transfusion (Malden, MA, US), 60, S96 (2020)Formule :C7H13NO3SCouleur et forme :NeatMasse moléculaire :191.00N-Pyrazinylcarbonyl-L-phenylalanine Methyl Ester
CAS :Applications Used for the synthesis of Bortezomib from L-phenylalanine via dipeptidyl boronic acid ester intermediates.
References Zhu, Y., et al.: J. Med. Chem., 52, 4192 (2009),Formule :C15H15N3O3Couleur et forme :NeatMasse moléculaire :285.3Lisinopril (S,S,R)-Diketopiperazine (~90%)
CAS :Impurity Lisinopril EP Impurity D
Stability Hygroscopic
Applications Lisinopril (S,S,R)-Diketopiperazine (Lisinopril EP Impurity D) is an impurity of Lisinopril (L468985), an orally active angiotensin-converting enzyme (ACE) inhibitor (1).
References 1. Goa, K. et al.: Drugs. 1996 Oct;52(4):564-88.Formule :C21H29N3O4Degré de pureté :~90%Couleur et forme :White To Off-WhiteMasse moléculaire :387.47Teriparatide-d10
CAS :Produit contrôléFormule :C181D10H281N55O51S2Couleur et forme :NeatMasse moléculaire :4127.72Cyclosporin B
CAS :Applications An immunosuppressant that has revolutionized organ transplantation through its use in the prevention of graft rejection.A group of nonpolar cyclic oligopeptides with immunosupppressant activity.
References van Wartburg, A., et al.: Prog. Med. Chem., 25, 1 (1988), Jorgensen, K.A., et al.: Scand. J. Imunol., 57, 93 (2003), Vollenbroeker, et al.: Transplant. Proc., 37, 1741 (2005),Formule :C61H109N11O12Degré de pureté :>80%Couleur et forme :NeatMasse moléculaire :1188.58N-2-(Hydroxyethyl)-L-valine-d4 (Technical grade)
CAS :Produit contrôléApplications Labelled N-2-(Hydroxyethyl)-L-valine (H942300). Cotinine and N-(2-hydroxyethyl)valine are markers of passive exposure to tobacco smoke in children.
References Dempsey, D., et al.: Clin. Pharmacol. Ther., 67, 458 (2000), Smith, C., et al.: Food Chem. Toxicol., 41, 807 (20030,Formule :C7H11D4NO3Couleur et forme :WhiteMasse moléculaire :165.22N-Formyl Thyroxine
CAS :Produit contrôléImpurity Levothyroxine N-Formyl Impurity; N-Formyl-T4 (USP)
Applications N-Formyl Thyroxine (Levothyroxine N-Formyl Impurity; N-Formyl-T4 (USP)) is a thyroxine derivative which showed less thyroid activity than Thyroxine Sodium (T425601).
References Basil, B., et al.: Br. J. Pharmacol. Chemother., 5, 315 (1950),Formule :C16H11I4NO5Couleur et forme :NeatMasse moléculaire :804.88Bortezomib-D8 (Major)
CAS :Produit contrôléApplications Labelled Bortezomib, which the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells.d6-3%d7-10%d8-86%
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005)Formule :C19H17D8BN4O4Couleur et forme :Off-WhiteMasse moléculaire :392.29Cyclosporin C
CAS :Produit contrôléApplications A group of nonpolar cyclic oligopeptides with immunosupppressant activity.
References van Wartburg, A., et al.: Prog. Med. Chem., 25, 1 (1988), Jorgensen, K.A., et al.: Scand. J. Imunol., 57, 93 (2003), Vollenbroeker, et al.: Transplant. Proc., 37, 1741 (2005),Formule :C62H111N11O13Degré de pureté :>80%Couleur et forme :NeatMasse moléculaire :1218.61N-Acetyl-L-carnosine
CAS :Produit contrôléApplications Used in the treatment of cataracts and in the treatment of UV-induced immunosuppression. May act with with lipoic acid (L468725) to reverse age-related metabolic decline and also the indicies of oxidative stress.
References Babizhayev, M., et al.: J. Pharmacol. Toxicol., 1, 201 (2006), Min, J., et al.: J. Neurosci. Res., 86, 2984 (2008), Babizhayev, M., et al.: J. Drug Target., 17, 36 (2009); Hagen et. al, PNAS 99: 1870 (2002); Liu et. al, PNAS 99, 2356 (2002)Formule :C11H16N4O4Couleur et forme :Off-WhiteMasse moléculaire :268.27(2S,4S)-Sacubitril
CAS :Stability Moisture Sensitive
Applications (2S,4S)-Sacubitril is an impurity of Sacubitril (S080895) which is an antihypertensive drug used in combination with valsartan.
References McMurray, J., et al.: N. Eng. J. Med., 371 (2014);Formule :C24H29NO5Couleur et forme :NeatMasse moléculaire :411.49L-Carnitine-L-tartrate
CAS :Produit contrôléApplications L-Carnitine-L-tartrate (cas# 36687-82-8) is a useful research chemical.
Formule :C7H16NO3·C4H4O6Couleur et forme :White To Off-WhiteMasse moléculaire :472.48Bivalirudin Trifluoroacetic Acid Salt
CAS :Applications Bivalirudin Trifluoroacetic Acid Salt is an anticoagulant drug that is a direct thrombin inhibitor. It is used for treatment of acute coronary syndromes, and is a safer alternative to heparin due to lower rates of bleeding as an adverse effect of anticoagulant in patients.
References Stone, G., et al.: N. Engl. J. Med, 355, 2203 (2006); Stone, G., et al.: N Engl J Med, 358, 2218 (2008);Formule :C98H138N24O33·(C2HF3O2)xCouleur et forme :NeatMasse moléculaire :2180.29114026-Perdeoxy-6-perchloro-γ-cyclodextrin, >90%
CAS :Formule :C48H72Cl8O32Degré de pureté :>90%Couleur et forme :NeatMasse moléculaire :1444.69N-Nitroso-D,L-proline-d3
CAS :Produit contrôléApplications A labelled nitrosoamino acid with oncogenic activity.
References Nagasawa, H.T., et al.: J. Med. Chem., 16, 583 (1973)Formule :C52H3H5N2O3Couleur et forme :Off-WhiteMasse moléculaire :147.147Dihydro Cyclosporin A
CAS :Produit contrôléApplications A Cyclosporin A (C988900) analog, an immunosuppressant.
References Emmer, G., et al.: J. Med. Chem., 37, 1918 (1994), High, K., et al.: J. Biol. Chem., 269, 9105 (1994),Formule :C62H113N11O12Couleur et forme :WhiteMasse moléculaire :1204.633,3',5'-Triiodo-L-thyronine
CAS :Formule :C15H12I3NO4Couleur et forme :Light Beige To GreyMasse moléculaire :650.974-Methylbenzenesulfonic Acid Monohydrate
CAS :Produit contrôléImpurity Lisinopril EP Impurity B/ Anastrozole EP Impurity F
Applications 4-Methylbenzenesulfonic Acid Monohydrate (Lisinopril EP Impurity B) is used in the synthesis of resveratrol. Also used in the synthesis of oxane derivatives as antimalarial agents.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Davis, M. et al.: Org. Prep. Proc. Int., 45, 304 (2013); Wang, X. et al.: J. Med. Chem., 56, 2547 (2013);Formule :C7H8O3S·H2OCouleur et forme :WhiteMasse moléculaire :190.22(2R,4R)-Sacubitril
CAS :Applications (2R,4R)-Sacubitril is an impurity of Sacubitril (S080895) which is an antihypertensive drug used in combination with valsartan.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References McMurray, J., et al.: N. Eng. J. Med., 371 (2014);Formule :C24H29NO5Couleur et forme :NeatMasse moléculaire :411.491Bestatin
CAS :Bestatin (Ubenimex) competitively inhibits many aminopeptidases. Bestatin is a microbial metabolite and dipeptide with immunomodulatory and antitumor effects.Formule :C16H24N2O4Degré de pureté :98% - 99.63%Couleur et forme :White Crystalline PowderMasse moléculaire :308.37Ref: TM-T1257
2mg34,00€5mg52,00€1mL*10mM (DMSO)58,00€10mg64,00€25mg99,00€50mg157,00€100mg222,00€200mg330,00€L-Valine-d8
CAS :Produit contrôléApplications Labelled analogue of L-Vailne. L-Valine is an essential amino acid and one of 20 proteinogenic amino acids. L-Valine cannot be manufactured by the body and must be acquired through diet or supplementation. L-valine is found in grains, dairy products, mushrooms, meats, peanuts and soy proteins. L-Valine has been used in studies to attenuate arrhythmias and induce hypotensive effects.
References Choi, C.W. et al.: Anim. Feed Sci. Technol., 102, 15 (2002); Kolarski, D. et al.: Krmiva, 30, 155 (1988); Oba, M. et al.: J. Dairy Sci., 93, 2044 (2010); Mitrega, K. et al.: Pharmacol. Res., 64, 218 (2011);Formule :C52H8H3NO2Couleur et forme :NeatMasse moléculaire :125.24-(Phenylamino]-1-benzyl-4-piperidinecarboxylic Acid Methyl Ester
CAS :Produit contrôléApplications Remifentanil derivative.
References James, M.K., et al.: J. Pharmacol. Exp. Ther., 259, 712 (1991), Hoffman, W.E., et al.: Anesthesiology, 79, 107 (1993), Selinger, K., et al.: J. Pharm. Biomed. Anal., 12, 243 (1994), Richardson, T.D., et al.: Expert Opin. Drug Saf., 4, 643 (2005),Formule :C20H24N2O2Couleur et forme :NeatMasse moléculaire :324.4168Protoporphyrin-9
CAS :Stability Light Sensitive
Applications Protoporphyrin-9 is the precursor to heme sites and chlorophyll.Formule :C34H34N4O4Couleur et forme :NeatMasse moléculaire :562.665-9-Leuprolide xTFA Salt
CAS :Produit contrôléApplications 5-9-Leuprolide is a metabolite of Leuprolide (L330590), a gonadotropin-releasing hormone (GnRH) analogue acting as an agonist at pituitary GnRH receptors.
References Handelsman, David J., et al.: J. of Steroid Biochem. and Mol. Bio., 141, 113-120 (2014);Okada, Hiroaki, et al.: Pharma. Res., 8(6), 787-91 (1991)Formule :C34H57N9O6·x(C2HF3O2)Couleur et forme :NeatMasse moléculaire :801.9Liraglutide
CAS :Produit contrôléFormule :C172H265N43O51Couleur et forme :Off-WhiteMasse moléculaire :3751.2GSK1904529A
CAS :GSK1904529A (GSK 4529) is a specific inhibitor of IGF-1R (IC50=27 nM) and IR(IC50=25 nM) .Formule :C44H47F2N9O5SDegré de pureté :98.2% - 99.76%Couleur et forme :SolidMasse moléculaire :851.96N-Nitroso-D-proline
CAS :Produit contrôléApplications A nitrosoamino acid with oncogenic activity. The LD50 of a single ip dose given to Swiss-Webster mice is 203 +/- 22 mg / kg.
References Nagasawa, H.T., et al.: J. Med. Chem., 16 (5), 583-585 (1973)Formule :C5H8N2O3Couleur et forme :NeatMasse moléculaire :144.13(1R,2R)-Bortezomib
CAS :Impurity Bortezomib USP Related Compound A
Applications (1R,2R)-Bortezomib is a diastereomer of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009)Formule :C19H25BN4O4Degré de pureté :>85%Couleur et forme :NeatMasse moléculaire :384.24(S)-Lisinopril Dimer
CAS :Produit contrôléApplications (S)-Lisinopril (L468985) impurity. Lisinopril Impurity G (Dimer Impurity)
Formule :C42H60N6O9Couleur et forme :WhiteMasse moléculaire :792.96β-Hydroxy Thyroxine (>90%)
CAS :Produit contrôléImpurity Levothyroxine beta-Hydroxy Impurity / Levothyroxine beta-Hydroxy T4 Impurity
Applications It has been prepared for testing as possible antithyroid. It showed some thyromimetic activity.
References Wawzone, S., et al.: J. Med. Chem., 6, 442 (1963),Formule :C15H11I4NO5Degré de pureté :>90%Couleur et forme :NeatMasse moléculaire :792.87Lisinopril Cyclohexyl Analogue
CAS :Produit contrôléImpurity Lisinopril EP Impurity F
Applications Lisinopril Cyclohexyl Analogue (Lisinopril EP Impurity F) is a Lisinopril (L468985) impurity.
References Paraskevas, G., et al.: J. Pharm. Biomed. Anal., 29, 865 (2002),Formule :C21H37N3O5Couleur et forme :NeatMasse moléculaire :411.54Sugammadex Sodium
CAS :Formule :C72H104O48S8·8NaCouleur et forme :White To BeigeMasse moléculaire :2178.00(R)-Lisinopril Sodium Salt
CAS :Applications R,S,S-Isomer of Lisinopril (L468985).
References Goa, K.L., et al.: Drugs, 52, 564 (1996), Chaturvedi, N., et al.: Lancet, 351, 28 (1998)Formule :C21H31N3NaO5Couleur et forme :NeatMasse moléculaire :428.48(R)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acid
CAS :Produit contrôléApplications (R)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acid, is an amino acid building block used in peptide synthesis. With a growing peptide drug market the fast, reliable synthesis of peptides is of great importance.
Formule :C10H11NO2Couleur et forme :NeatMasse moléculaire :177.2rhPTH (1-30) Trifluoroacetic Acid Salt Hydrate
Produit contrôléImpurity Teriparatide Impurity
Applications A fragment of human parathyroid hormone (hPTH) peptide sequence containing the 30 N-terminal residues of hPTH.
References Niall, et al.: Proc. Natl. Acad. Sci., 71, 384 (1974);Formule :C157H260N48O46S2•x(C2HF3O2)•y(H2O)Couleur et forme :NeatMasse moléculaire :3620.171140218Sacubitril Calcium
CAS :Applications Sacubitril is an antihypertensive drug used in combination with valsartan. The combination drug, valsartan/sacubitril, known during trials as LCZ696 and marketed under the brand name, Entresto, is a treatment for heart failure.
References McMurray, J., et al.: N. Eng. J. Med., 371 (2014)Formule :C24H28NOCa2Couleur et forme :NeatMasse moléculaire :430.52Oxytocin Acetate
CAS :Applications Oxytocin Acetate is the principal uterus-contracting and lactation-stimulating hormone of the posterior pituitary gland.
References Pierce, et al.: J. Biol. Chem., 199, 929 (1952), Tuppy, et al.: Biochem. Biophys. Acta, 11, 449 (1953), Cash, et al.: J. Med. Pharm. Chem., 5, 413 (1962), Nachtmann, F., et al.: Anal. Profiles Drug Subs., 10, 563 (1981),Formule :C43H66N12O12S2·C2H4O2Couleur et forme :White To Off-WhiteMasse moléculaire :1067.24N-Glycylproline
CAS :Applications N-Glycylproline was found to exhibit anti-ischemic effects on the metabolism of neuroactive amino acids and indices of energy turnover in the neocortex of rats after experimental brain ischemia.
References Bashun, Z.N., et al.: Neurochem. J., 7, 39 (2013);Formule :C7H12N2O3Couleur et forme :NeatMasse moléculaire :172.182L-Methionine-34S
CAS :Applications Labelled L-Methionine, an essential aminoacid for human development. Hepatoprotectant; antidote (acetominophen poisoning); urinary acidifier.
References Benevenga, N.J., et al.: J. Agric. Food Chem., 22, 2 (1974), Fleisher, L.D., et al.: Clin. Endocrinol. Metab., 3, 37 (1974), Meinnel, T., et al.: Biochimie, 75, 1061 (1993),Formule :C5H11NO234SCouleur et forme :NeatMasse moléculaire :151.11N,N-Dimethyl-4-hydroxymethoxy Clomiphene (~90%, contains ~10% Z-isomer)
CAS :Produit contrôléFormule :C25H26ClNO3Couleur et forme :NeatMasse moléculaire :423.93(S)-Tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetic Acid
CAS :Produit contrôléFormule :C9H16N2O3Couleur et forme :NeatMasse moléculaire :200.23Sacubitril Sodium Salt
CAS :Formule :C24H28NO5·NaCouleur et forme :White To Off-WhiteMasse moléculaire :433.473Glecaprevir
CAS :Produit contrôléApplications Glecaprevir is an antiviral drug used in the treatment of patients with hepatitis C virus (HCV) genotype 1-6, of special interest for the treatment of patients with chronic kidney disease also suffering from HCV.
References Kwo, P., et. al.: J. Hepatol, 67, 263 (2017)Gane, E., et. al.: N. Engl. J. Med, 377, 1448 (2017)Formule :C38H46F4N6O9SCouleur et forme :NeatMasse moléculaire :838.86L-Thioproline
CAS :Applications L-Thioproline is used to create a monolayer on gold electrodes for the determination Copper(II). L-Thioproline has shown to be an effect inhibitor of proline absorption in Saccharomyces chevalieri.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Cui, X., et. al.: Sci. China Chem., 53, 257 (2010); Magana-Schwenchke, N., Schwencke, J.: BBA-Biomembranes, 173, 313 (1969)Formule :C4H7NO2SCouleur et forme :NeatMasse moléculaire :133.17Methionine
CAS :Methionine (D-Methionine) (MRX-1024; D-Methionine) is an effective chemoprotective agent which can also inhibit the neuronal activity through GABAA receptorFormule :C5H11NO2SDegré de pureté :99.13% - 99.62%Couleur et forme :SolidMasse moléculaire :149.21Carfilzomib
CAS :Produit contrôléApplications Carfilzomib is a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma.
References Fostier, K., et al.: Oncotargets. Therap., 5, 237 (2012); Geurink, P.P., et al.: J. Med. Chem., 56, 1262 (2013); McCormack, P.L., et al.: Drugs., 72, 2023 (2012);Formule :C40H57N5O7Couleur et forme :White To Off-WhiteMasse moléculaire :719.91Tabimorelin
CAS :Produit contrôléApplications NN703 (Tabimorelin) is an orally active growth hormone (GH) secretagogue intended for use as an alternative to daily injections of GH. In vitro studies in human liver microsomes have indicated that NN703 is a mechanism-based inhibitor of CYP3A4.
References Fabre, G., et al.: Biochem. Pharmacol., 37, 4389 (1988), Thummel, K., et al.: Clin. Pharmacol. Ther., 59, 491 (1996), Yu, D., et al.: J. Clin. Pharmacol., 39, 1203 (1999),Formule :C32H40N4O3Couleur et forme :NeatMasse moléculaire :528.68Sacubitril
CAS :Formule :C24H29NO5Couleur et forme :Off-White To Light YellowMasse moléculaire :411.49N-Nitroso Lisinopril
CAS :Formule :C21H30N4O6Couleur et forme :White To Light YellowMasse moléculaire :434.486Perfluorophenol
CAS :Produit contrôléApplications Perfluorophenol is used in the synthesis of PGA-films as biodegradable polymers. It also participates in the synthesis of tripod macrocyclic Gd(III) chelates for cancer molecular MRI.
References Lee, K. et al.: Langmuir., 20, 2531 (2004); Zhou, Z. et al.: Biomater., 34, 7683 (2013);Formule :C6HF5OCouleur et forme :NeatMasse moléculaire :184.06(R)-Hydroxy Des(boric Acid) Bortezomib
CAS :Produit contrôléImpurity Bortezomib USP Impurity I
Applications (R)-Hydroxy Des(boric acid) Bortezomib is an impurity in the synthesis of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.
References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C. et al.: Chem. and Eng. News, 87, 41 (2009)Formule :C19H24N4O3Couleur et forme :NeatMasse moléculaire :356.42Bortezomib
CAS :Produit contrôléStability Hygroscopic and Moisture Sensitive
Applications Bortezomib is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009);Formule :C19H25BN4O4Couleur et forme :White To Off-WhiteMasse moléculaire :384.24Voclosporin-d4
CAS :Produit contrôléApplications Labelled Voclosporin (V678500). A new agent for the treatment of noninfectious uveitis. Uveitis is an inflammatory, putative Th1-mediated autoimmune disease that affects various parts of the eye and is a leading cause of visual loss. Voclosporin, a rationally designed novel calcineurin inhibitor, exhibits a favorable safety profile, a strong correlation between pharmacokinetic and pharmacodynamic response, and a wide therapeutic window. Immunosuppressant.
References Aspeslet, L., et al.: Transplant Proc., 33, 1048 (2001), Cho, M., et al.: Arthritis Rheum., 46, 1202 (2002), Staatz, C., et al.: Clin. Pharmacokinet., 43, 623 (2004),Formule :C63H107D4N11O12Couleur et forme :NeatMasse moléculaire :1218.65Gramicidin (Technical Grade)
CAS :Produit contrôléFormule :C99H140N20O17Couleur et forme :Off-WhiteMasse moléculaire :1882.3Cyclosporin G
CAS :Produit contrôléFormule :C63H113N11O12Couleur et forme :NeatMasse moléculaire :1216.64Teduglutide-d8 TFA salt x hydrate (Leu-methyl-d3+Phe-d5)
CAS :Produit contrôléApplications Teduglutide-d8 TFA salt x hydrate (Leu-methyl-d3+Phe-d5) is an isotopically labelled form of Teduglutide (T013795), which is glucagon-like peptide-2 (GLP-2) analogue that is used for the treatment of short bowel syndrome.
References Jeppesen, P., et al.: Gut, 54, 1224 (2005)
Chemical Name: Jeppesen, P., et al.: Gut, 54, 1224 (2005)Formule :C164H244D8N44O55S•C2HF3O2•x(H2O)Couleur et forme :NeatMasse moléculaire :3760.081140218L-Methionine Sulfoxide
CAS :Stability Temperature Sensitive, Hygroscopic
Applications An intermediate in the synthesis of the acyclic amino carboxylic acid L-Methionine sulfoximine.
References Lee, B., et al.: J. Biol. Chem., 283, 28361 (2008), Nordqvist, A., et al.: Bioorg. Med. Chem., 16, 5501 (2008), Balog, E., et al.: Biochem., 48, 3005 (2009),Formule :C5H11NO3SCouleur et forme :White To BeigeMasse moléculaire :165.213,3’,5-Triiodo-L-thyronine 4’-O-Sulfate
CAS :Applications 3,3’,5-Triiodo-L-thyronine 4’-O-Sulfate is the sulfoconjugated metabolite of 3,3’,5-Triiodo-L-thyronine (T795380).
References Rooda, S.J. et al.: J. Clin. Endocrinol. Metab., 69, 552 (1989); Everts, M. E. et al.: Metab. Clin. Exp., 43, 1282 (1994); Pinna, G. et al.: Endocrinology, 143, 1789 (2002);Formule :C15H12I3NO7SCouleur et forme :NeatMasse moléculaire :731.04Glucagon-d9 Trifluoroacetate
CAS :Produit contrôléFormule :C153H216D9N43O49Sx(C2HF3O2)Couleur et forme :NeatMasse moléculaire :3491.8(1S,2S)-Bortezomib
CAS :Produit contrôléImpurity Bortezomib USP Impurity G
Stability Hygroscopic
Applications (1S,2S)-Bortezomib is an isomer of Bortezomib (B675700), proteasome inhibitor. (1S,2S)-Bortezomib has been seen to inhibit serine proteases shown to lower cellular Aβ concentrations, associated with Alzheimer’s or hypertension.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Hardy, J. et al.: Science, 297, 353 (2002); Paris, D. et al.: Mol. Med. 17, 149 (2011);Formule :C19H25BN4O4Couleur et forme :NeatMasse moléculaire :384.24Teduglutide Trifluoroacetic Acid Salt
Applications Teduglutide TFA Salt is a polypeptide consisting of 33 amino acids. It is glucagon-like peptide-2 (GLP-2) analogue that is used for the treatment of short bowel syndrome.
References Jeppesen, P., et al.: Gut, 54, 1224 (2005)Formule :C164H252N44O55S•x(C2HF3O2)Couleur et forme :NeatMasse moléculaire :3752.13 + x(114.02)Thyroxine Methyl Ester
CAS :Produit contrôléApplications Thyroxine Methyl Ester is the methyl ester analog of Thyroxine (T425600) with high cross reactivity with thyroxine-specific monoclonal antibodies of humans and lab animals. It is an inhibitor of malate dehydrogenase.Thyroxine Methyl Ester is suitable for malate dehydrogenase (MDH) related research.
References Mpoko, C.N. et al.: Clin. Chim. Acta, 146, 215 (1985); Maggio, E.T. et al.: Biochim. Biophys. Acta Enzymol., 522, 284 (1978);Formule :C16H13I4NO4Couleur et forme :NeatMasse moléculaire :790.9Sugammadex Sodium-deuterated
CAS :Produit contrôléApplications Sugammadex Sodium-deuterated, is the labaled analogue of Sugammadex Sodium (S698100), which is the first in a class of drugs called selective relaxant binding agents that offers improved termination of the paralytic effects of neuromuscular blocking agents and may have many potential peri-operative benefits.
References Welliver, M., et al.: Drug Des. Devel. Ther., 2, 49 (2008);Formule :C72H104Na8O48S8forundeuteratedCouleur et forme :NeatMasse moléculaire :2178.006Cyclosporin D
CAS :Produit contrôléApplications A group of nonpolar cyclic oligopeptides with immunosupppressant activity.
References van Wartburg, A., et al.: Prog. Med. Chem., 25, 1 (1988), Jorgensen, K.A., et al.: Scand. J. Imunol., 57, 93 (2003), Vollenbroeker, et al.: Transplant. Proc., 37, 1741 (2005),Formule :C63H113N11O12Couleur et forme :Off-WhiteMasse moléculaire :1216.642,5-Dioxopyrrolidine Sacubitril
CAS :Applications Sacubitril Impurity 2 is an impurity of Sacubitril (S080895) which is an antihypertensive drug used in combination with valsartan.
References McMurray, J., et al.: N. Eng. J. Med., 371 (2014);Formule :C24H27NO4Couleur et forme :White To Off-WhiteMasse moléculaire :393.48Thyroxine Sodium Salt
CAS :Produit contrôléStability Hygroscopic
Applications One of the thyroid hormones involved in the maintenance of metabolic homeostasis. Synthesized and stored as amino acid residues of thyroglobulin, the major protein component of the thyroid follicular colloid. Synthesis and secretion are regulated by the pituitary hormone (TSH). Deiodinated in peripheral tissues to the active metabolite, liothyronine. The D-form has very little activity as a thyroid hormone, but has been used to treat hyperlipidemia.
References Post, A., et al.: Anal. Profiles Drug Subs., 5, 225 (1976), Nelson, J.C., et al.: Clin. Chem., 34, 1737 (1988), Fischer, D.A., et al.: Clin. Chem., 42, 135 (1996), Cavalieri, R.R., et al.: Thyroid, 7, 177 (1997),Formule :C15H10I4NO4·NaCouleur et forme :NeatMasse moléculaire :798.85Bivalirudin Plus-Gly Fragment Trifluoroacetic Acid Salt (Impurity)
Applications Impurity of Bivalirudin, a direct thrombin inhibitor acting as an anticoagulant through inhibition of the enzyme thrombin.
References Bertrand, O. et al.: Am. J. Cardio., 110, 599 (2012); Patti, G. et al.: Am. J. Cardio., 110, 478 (2012);Formule :C100H141N25O34•xC2HF3O2Couleur et forme :NeatMasse moléculaire :2338.4Romidepsin
CAS :Produit contrôléApplications Romidepsin is a histone deacetylase inhibitor that can alter chromatin structure and gene transcription leading to multiple changes in cellular protein production. This may result in cell cycle arrest and tumor growth inhibition. Romidepsin has shown anti-proliferative activity in vitro against multiple mouse and human tumor cell lines and in vivo in human tumor xenograft models. Romidepsin can be administered with a second agent, such as a cytotoxic agent, a steroidal agent, a proteasome inhibitor, or a kinase inhibitor.
References Ueda, H., et al.: J. Antibiot., 47, 301 (1994), Weidle, U., et al.: Anticancer Res., 20, 1471 (2000), Kitazono, M., et al.: Cancer Res., 61, 6328 (2001), Sandor, V., et al.: Clin. Cancer Res., 8, 718 (2002),Formule :C24H36N4O6S2Couleur et forme :White To Off-WhiteMasse moléculaire :540.7Teduglutide
CAS :Teduglutide (ALX-0600) is a glucagon-like peptide-2 analog that increases intestinal absorption and can be used in research on short bowel syndrome (SBS).Formule :C164H252N44O55SDegré de pureté :98.08%Couleur et forme :SolidMasse moléculaire :3752.0813C6-Lys Octreotide Trifluoroacetate
CAS :Produit contrôléFormule :C4313C6H66N10O10S2•xC2HF3O2Couleur et forme :White To Off-WhiteMasse moléculaire :1025.2011402Lopinavir
CAS :Stability Hygroscopic
Applications A selective HIV protease inhibitor. An analogue of Ritonavir. Antiviral. It is a COVID19-related research product.
References Sham, H.L., et al.: Antimicrob. Ag. Chemother., 42, 3218 (1998), Kumar, G.N., et al.: Drug Metab. Dispos., 27, 86 (1999), Murphy, R.L., et al.: Antiviral Ther., 4, Suppl. 3, 85 (1999)Formule :C37H48N4O5Couleur et forme :White SolidMasse moléculaire :628.8Tert-butyl Acetate
CAS :Produit contrôléApplications Tert-butyl Acetate is a common solvent used in the production of various industrial cleansers, thinners and adhesives and is also known as a VOC.Environmental contaminants; Food contaminants
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Mackay, D., et al.: SAR. QSAR. Enviro. Res., 23, 205 (2012); Yang, Y.S., et al.: Toxicol. Res., 26, 293 (2010);Formule :C6H12O2Couleur et forme :ColourlessMasse moléculaire :116.16Lopinavir Metabolite M-1
CAS :Produit contrôléApplications A major metabolite of Lopinavir (L469480) . It is a COVID19-related research product.
References Molla, A., et al.: J. Virology, 250, 255 (1998), Sham, H., et al.: Antimicrob. Agents Chemother., 42, 3218 (1998), Kumar, G., et al.: Drug Metab. Dispos., 27, 86 (1999),Formule :C37H46N4O6Couleur et forme :NeatMasse moléculaire :642.783,5,3',5'-Tetraiodo Thyromandelic Acid (>85%)
CAS :Produit contrôléImpurity Levothyroxine T4-Hydroxyacetic Acid; T4-Hydroacetic Acid (USP)
Stability Hygroscopic
Applications 3,5,3',5'-Tetraiodo Thyromandelic Acid (Levothyroxine T4-Hydroxyacetic Acid; T4-Hydroacetic Acid (USP)) is a thyroid hormone analogue, a Thyroxine (T425600) impurity.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Horst, C., et al.: Biochem. J., 261, 945 (1989), Kvetny, J., et al.: Horm. Metab. Res., 24, 322 (1992), Yamauchi, K., et al.: J. Biol. Chem., 274, 8460 (1999), Davis, P., et al.: J. Endocrinol. Invest., 25, 377 (2002),Formule :C14H8I4O5Degré de pureté :>85%Couleur et forme :Light Orange Colour To BrownMasse moléculaire :763.83Thyroxine 4’-O-β-D-Glucuronide
CAS :Applications Thyroxine 4-O-β-D-Glucuronide is a major metabolite and glucuronide conjugate of Thyroxine (T425600) formed via the glucuronidation of the phenyl hydroxyl group.
References Tong, Z. et al.: Drug Metab. Dispos., 35, 2203 (2007); West, C.D. et al.: J. Clin. INvest., 42, 1134 (1963);Formule :C21H19I4NO10Couleur et forme :NeatMasse moléculaire :952.99Pidotimod
CAS :Produit contrôléApplications Immunostimulant used in patients with cell-mediated immunodepression.
References Gu, C., et al.: Pharm. Res., 25, 979 (2008), Fliri, A., et al.: J. Med. Chem., 52, 8038 (2009), Giagulli, C., et al.: Int. Immunopharmacol., 9, 1366 (2009),Formule :C9H12N2O4SCouleur et forme :NeatMasse moléculaire :244.27γ-Cyclodextrin
CAS :Stability Hygroscopic
Applications γ-Cyclodextrin is used as nanomolecular encapsulation for drug delivery and pharmaceuticals. Used in the synthesis of unilamellar vesicles.
References Ikeda, A. et al.: Chem. Comm., 50, 1288 (2014); Gudmundsdottir, B. et al.: J. Ocular Pharm. Ther., 30, 35 (2014);Formule :C48H80O40Couleur et forme :WhiteMasse moléculaire :1297.123-Mercaptopropionic Acid
CAS :Produit contrôléApplications 3-Mercaptopropionic Acid (cas# 107-96-0) is a compound useful in organic synthesis.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the packageFormule :C3H6O2SCouleur et forme :NeatMasse moléculaire :106.14Lopinavir-D8
CAS :Produit contrôléApplications A labelled selective HIV protease inhibitor. An analogue of Ritonavir. Antiviral. It is a COVID19-related research product.
References Sham, H.L., et al.: Antimicrob. Ag. Chemother., 42, 3218 (1998), Kumar, G.N., et al.: Drug Metab. Dispos., 27, 86 (1999), Murphy, R.L., et al.: Antiviral Ther., 4, Suppl. 3, 85 (1999)Formule :C37D8H40N4O5Couleur et forme :Light YellowMasse moléculaire :636.85L-Methionine
CAS :Applications Essential aminoacid for human development. Hepatoprotectant; antidote (acetominophen poisoning); urinary acidifier.
References Benevenga, N.J., et al.: J. Agric. Food Chem., 22, 2 (1974), Fleisher, L.D., et al.: Clin. Endocrinol. Metab., 3, 37 (1974), Meinnel, T., et al.: Biochimie, 75, 1061 (1993),Formule :C5H11NO2SCouleur et forme :White To Off-WhiteMasse moléculaire :149.21Desethyl Sacubitril-d4
CAS :Produit contrôléFormule :C22H21D4NO5Couleur et forme :NeatMasse moléculaire :387.46Oxytocin-d5 Trifluoroacetate
CAS :Produit contrôléApplications Labelled Oxytocin. The principal uterus-contracting and lactation-stimulating hormone of the posterior pituitary gland.
References Pierce, et al.: J. Biol. Chem., 199, 929 (1952), Tuppy, et al.: Biochem. Biophys. Acta, 11, 449 (1953), Cash, et al.: J. Med. Pharm. Chem., 5, 413 (1962), Nachtmann, F., et al.: Anal. Profiles Drug Subs., 10, 563 (1981),Formule :C45H62D5F3N12O14S2Couleur et forme :White To Off-WhiteMasse moléculaire :1126.24Carfilzomib (2R,4R)-Diol
Produit contrôléApplications Carfilzomib (2R,4R)-Diol is a derivative of Carflizomib (C183460), a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma.
References Fostier, K., et al.: Oncotargets. Therap., 5, 237 (2012); Geurink, P.P., et al.: J. Med. Chem., 56, 1262 (2013); McCormack, P.L., et al.: Drugs., 72, 2023 (2012);Formule :C40H59N5O8Couleur et forme :NeatMasse moléculaire :737.93Eptifibatide
CAS :Produit contrôléApplications An arginine-glycine-aspartate-mimetic, reversibly binds to platelets to reduce the risk of cardiac ischemic events.
References Pathak, A., et al.: Cardiovas. Diabetol., 7 (2008), Hantgan, R., et al.: Biochem., 48, 8355 (2009), Giugliano, R., et al.: New Eng. J. Med., 360, 2176 (2009),Formule :C35H49N11O9S2Couleur et forme :Off White SolidMasse moléculaire :831.963,3',5,5'-Tetraiodo Thyroformic Acid (>90%)
CAS :Impurity Levothyroxine EP Impurity H; T4-Benzoic Acid (USP)
Applications 3,3',5,5'-Tetraiodo Thyroformic Acid (Levothyroxine EP Impurity H; T4-Benzoic Acid (USP)) is a thyroid hormone analogue and a potent Thyroxine impurity.
References Horst, C., et al.: Biochem. J., 261, 945 (1989), Kvetny, J., et al.: Horm. Metab. Res., 24, 322 (1992), Yamauchi, K., et al.: J. Biol. Chem., 274, 8460 (1999), Davis, P., et al.: J. Endocrinol. Invest., 25, 377 (2002),Formule :C13H6I4O4Degré de pureté :>90%Couleur et forme :White To Light BrownMasse moléculaire :733.8D-Ser(11)-Semaglutide
D-Ser(11)-Semaglutide is a semaglutide impurity. The amino acid at position 11 has been replaced by the D-form of the amino acid D-serine (D-Ser). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/mol3,3',5,5'-Tetraiodothyroformic acid
CAS :Cymit Quimicaetic beta-D-glucosiduronic acidFormule :C13H6I4O4Degré de pureté :Min. 95 Area-%Couleur et forme :Off-White PowderMasse moléculaire :733.8 g/molD-Val(10)-Semaglutide
D-Val(10)-Semaglutide is a semaglutide impurity. The amino acid at position 10 has been replaced by the D-form of the amino acid D-valine (D-Val). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molD-Asp(9)-Semaglutide
D-Asp(9)-Semaglutide is a semaglutide impurity. The amino acid at position 9 has been replaced by the D-form of the amino acid D-aspartic acid (D-Asp). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.
Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molD-His(1)-Semaglutide
D-His(1)-Semaglutide is a semaglutide impurity. The amino acid at position 1 has been replaced by the D-form of the amino acid D-histidine (D-His). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molD-Ser-(12)-Semaglutide
D-Ser(12)-Semaglutide is a semaglutide impurity. The amino acid at position 12 has been replaced by the D-form of the amino acid D-serine (D-Ser). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molSemaglutide Impurity 56 (D-Glu 21)
D-Glu(21)-Semaglutide is a semaglutide impurity. The amino acid at position 21 has been replaced by the D-form of the amino acid D-glutamic acid (D-Glu). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molD-Phe(6)-Semaglutide
D-Phe(6)-Semaglutide is a semaglutide impurity. The amino acid at position 6 has been replaced by the D-form of the amino acid D-phenylalanine (D-Phe). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molD-Ser(8)-Semaglutide
D-Ser(8)-Semaglutide is a semaglutide impurity. The amino acid at position 8 has been replaced by the D-form of the amino acid D-serine (D-Ser). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/mol(R)-3-Methyl-1-(pyrazine- 2-carboxamido)butylboronic acid
The compound is a drug product, analytical, and research material. The molecule has been synthesized and purified by the company's chemists. It is not an API impurity but an impurity standard for HPLC. This compound is a synthetic chemical that does not occur naturally in any living organism. It has been developed for use in drug development and research. The compound was custom synthesized by the company's chemists to meet customer demand for high purity standards of this compound. It is used as a pharmacopoeia standard for HPLC analysis and drug development.Degré de pureté :Min. 95%Lisinopril EP Impurity E
CAS :Lisinopril EP Impurity E is an impurity of lisinopril, which is a prescription drug used to treat high blood pressure. This impurity was found in a preparative high performance liquid chromatography (HPLC) and mass spectroscopy analysis of the drug. The molecular weight of Lisinopril EP Impurity E was determined to be 317.2 amu, which corresponds to the molecular formula C7H13NO2. The FT-IR spectrum showed that this impurity has an ammonium group at 1859 cm-1 and butanoic acid at 1647 cm-1.Formule :C21H31N3O5Degré de pureté :Min. 98 Area-%Couleur et forme :PowderMasse moléculaire :405.49 g/molLinear Semaglutide
Linear semaglutide, or simply L-Sema, is the semaglutide compound without the lipid side chain modification. It is essentially a linear version of the peptide.Formule :C152H230N42O47Masse moléculaire :3,397.76 g/molSemaglutide Impurity 51 (D-Thr 7)
D-Thr(7)-Semaglutide is a semaglutide impurity. The amino acid at position 7 has been replaced by the D-form of the amino acid D-threonine (D-Thr). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molD-Ala-(19)-Semaglutide
D-Ala(19)-Semaglutide is a semaglutide impurity. The amino acid at position 19 has been replaced by the D-form of the amino acid D-alanine (D-Ala). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molSemaglutide Impurity 60 (D-Arg 30)
D-Arg(30)-Semaglutide is a semaglutide impurity. The amino acid at position 30 has been replaced by the D-form of the amino acid D-arginine (D-Arg). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molD-Thr(5)-Semaglutide
D-Thr(5)-Semaglutide is a semaglutide impurity. The amino acid at position 5 has been replaced by the D-form of the amino acid D-threonine (D-Thr). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molDes-Glu(3)-Semaglutide
Des-Glu(3)-semaglutide is a semaglutide-related impurity. This des-amino acid form has got the glutamic acid or glutamate (Glu) amino acid from position 3 removed from the peptide chain. Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist used for managing type 2 diabetes and obesity.Formule :C182H284N44O56Masse moléculaire :3,984.53 g/molDes-His(1)-Semaglutide
Des-His(1)-semaglutide is a semaglutide-related impurity. This des-amino acid form has the histidine (His) amino acid from position 1 removed from the peptide chain. Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist used for managing type 2 diabetes and obesity.Formule :C181H284N42O58Masse moléculaire :3,976.5 g/molBortezomib intermediate I
CAS :Bortezomib intermediate I is a metabolite of bortezomib, which is a research and development drug product. Bortezomib intermediate I is an impurity standard for bortezomib. Bortezomib intermediate I can be synthesized from the corresponding compound. It is an analytical standard used in pharmacopoeia and can be used as an API impurity or synthetic material in drug development. Bortezomib intermediate I has a high purity, natural origin, and a niche application. CAS No. 1248339-44-7Formule :C25H36BN5O4Degré de pureté :Min. 95%Couleur et forme :White PowderMasse moléculaire :481.4 g/molD-Ala(24)-Semaglutide
D-Ala(24)-Semaglutide is a semaglutide impurity. The amino acid at position 24 has been replaced by the D-form of the amino acid D-alanine (D-Ala). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molSemaglutide Impurity 101 (D-Glu 3)
D-Glu(3)-Semaglutide is a semaglutide impurity. The amino acid at position 3 has been replaced by the D-form of the amino acid D-glutamic acid (D-Glu). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molSemaglutide Impurity 59
D-Arg(28)-Semaglutide is a semaglutide impurity. The amino acid at position 28 has been replaced by the D-form of the amino acid D-arginine (D-Arg). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.
Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molSemaglutide Impurity 29 (β-Asp-9)
Beta-Asp-(9)-Semaglutide is a semaglutide impurity. The amino acid at position 9 has been replaced by the beta-aspartic acid (also known as isoaspartic, isoAsp, β-Asp or beta-Asp). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molSemaglutide Impurity 54 (D-Ala 18)
D-Ala(18)-Semaglutide is a semaglutide impurity. The amino acid at position 18 has been replaced by the D-form of the amino acid D-alanine (D-Ala). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/mol(S,E)-N-(1-(3-Methylbut-1-enylamino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide
CAS :R-N-(1-(3-methylbut-1-enyl)-1-oxo-3-phenylpropan-2-yl) pyrazine-2-carboxamide is a drug product that is used for the treatment of bacterial infections. The compound is an impurity in the synthesis of other compounds and is also used as an analytical standard. It is synthesized from commercially available starting materials and through custom synthesis. R-N-(1-(3-methylbut-1-enyl)-1--oxo--3--phenylpropan--2--yl)pyrazine--2--carboxamide has been shown to be metabolized by CYP450 enzymes, which are responsible for the metabolism of many drugs. R-(1-(3Methylbut 1Enylamino)-1Oxo 3Phenylpropan 2Yl)Pyrazine 2Carboxamide has not been evaluated as a drug product and therefore does notFormule :C19H22N4O2Degré de pureté :Min. 95%Masse moléculaire :338.4 g/molLisinopril
CAS :Lisinopril, an ACE inhibitor, treats hypertension, heart failure, heart attacks, and prevents diabetes-related eye and kidney issues.Formule :C21H31N3O5Degré de pureté :97.59% - 99.34%Couleur et forme :SolidMasse moléculaire :405.49(S)-(-)-α-Methylbenzylamine
CAS :Produit contrôléApplications (S)-(-)-α-Methylbenzylamine (cas# 2627-86-3) is a compound useful in organic synthesis.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the packageFormule :C8H11NCouleur et forme :NeatMasse moléculaire :121.18(2,6-Dimethylphenoxy)acetic Acid
CAS :Produit contrôléFormule :C10H12O3Couleur et forme :NeatMasse moléculaire :180.24-(Phenylamino)-1-benzyl-4-piperidinecarboxamide
CAS :Produit contrôléApplications Used as modulators of muscarinic receptors for treatment of CNS disorders.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Coghlan, M., et al.: J. Med. Chem., 44, 1627 (2001), Ashcroft, F., et al.: J. Clin. Invest., 115, 2047 (2005), Bryan, J., et al.: Curr. Pharm. Des., 11, 2699 (2005),Formule :C19H23N3OCouleur et forme :NeatMasse moléculaire :309.41N2-(S)-1-Carboxy-3-phenylpropyl-L-lysine
CAS :Produit contrôléStability Hygroscopic
Applications Lisinopryl impurity.
References Goa, K.L., et al.: Drugs, 52, 564 (1996), Cao, X.J., et al.: J. Pharm. Biomed. Anal., 39, 39 (2005),Formule :C16H24N2O4Couleur et forme :White To Light BeigeMasse moléculaire :308.37Semaglutide impurity
CAS :Lipid chain (stearic bi-acid) plus γ-glutamic acid or glutamate (γ-Glu) amino acid.Formule :C35H63N3O13Masse moléculaire :733.89 g/molCP5V
CAS :CP5V, a PROTAC, degrades Cdc20, halts mitosis, and inhibits cancer growth by targeting it for VHL-mediated ubiquitination and proteasome destruction.Formule :C46H66Cl3N9O12SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :1075.49Lysipressin amide, acetate
CAS :Lysipressin amide, acetate is an analog of vasopressin, a powerful vasopressin used to regulate blood pressure. Endogenous vasopressin in most mammalian species.Formule :C48H68N12O15S2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :1117.26Lisinopril (8R,S)-Diketopiperazine (Mixture of Diastereomers)Mps1-IN-1 dihydrochloride
CAS :Produit contrôléStability Hygroscopic
Applications Lisinopril (L468985) impurity.
References Drummer, O., et al.: Arzneim.-Forsch. Drug Res., 38, 647 (1988), Simpson, K., et al.: Drugs, 59, 1149 (2000),Formule :C21H29N3O4Couleur et forme :NeatMasse moléculaire :387.47Linear Daptomycin Hydrochloride Salt
CAS :Applications Linear Daptomycin Hydrochloride Salt is the hydrochloride salt of L466470, which is the open-conformation of Daptomycin (D193350), cyclic lipopeptide antibiotic derived from a fermentation product of Streptomyces roseosporus; disrupts plasma membrane function in gram-positive bacteria. Antibacterial. Daptomycin Impurity
References Allen, N.E., et al.: Antimicrob. Agents Chemother., 31, 1093 (1987), Tully, F.P., et al.: Expert Opin. Invest. Drugs, 8, 1223 (1999),Formule :C72H103N17O27·x(ClH)Degré de pureté :~80%Couleur et forme :NeatMasse moléculaire :1675.1(S)-Lisinopril-d5 Sodium
CAS :Produit contrôléFormule :C21H26D5N3NaO5Couleur et forme :NeatMasse moléculaire :433.51Dodecyl Polyoxyethylene (23) Aldehyde
CAS :Produit contrôléApplications Polyoxyethylene (23) Lauric Acid is an intermediate in the synthesis of Bril L-23 Proline (LIFETC1), a polyethylene glycol derivative of Proline (P755995), an amino acid and precursor (with vitamin C) for collagen, the building block of the structure of tendons, ligaments, arteries, veins and muscles.
References Bondarenko, L.B., et al.: Int. J. Peptides., 2, 1687 (2012); Rimer, T., et al.: Biomacromolecules, 13, 2110 (2012);Formule :C14H28O2(C2H4O)nCouleur et forme :NeatMasse moléculaire :272.42(S)-Hydroperoxy Des(boric Acid) Bortezomib
CAS :Produit contrôléApplications (S,S)-Hydroperoxy Des(boric Acid) Bortezomib is an impurity of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer.
References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009);Formule :C19H24N4O4Couleur et forme :NeatMasse moléculaire :372.42Voclosporin M1 (IM1-Diol-1) metabolite
Formule :C63H113N11O14Degré de pureté :>85%Couleur et forme :NeatMasse moléculaire :1248.66Cyclosporin AM 4N
CAS :Produit contrôléFormule :C61H109N11O12Couleur et forme :NeatMasse moléculaire :1188.58N(1-(3-Methylbutanamido) N(1-Des(boric Acid)) Bortezomib
CAS :Produit contrôléApplications N(1-(3-Methylbutanamido) N(1-Des(boric Acid)) Bortezomib is an impurity of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer.
References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009);Formule :C19H22N4O3Couleur et forme :White To Off-WhiteMasse moléculaire :354.403Trofinetide (>90%)
CAS :Produit contrôléApplications Trofinetide is a synthetic analogue of the endogenous N-terminus tripeptide, Glycine-Proline-Glutamate (GPE), that has shown to be neuroprotective in animal models of brain injury.
References Wei, H.H. et al.: J Neuroinflammation. 2009 Aug 5;6:19.Formule :C13H21N3O6Degré de pureté :>90%Couleur et forme :NeatMasse moléculaire :315.32t-Butyl 4-Bromobutanoate
CAS :Produit contrôléApplications t-Butyl 4-bromobutanoate is a useful research chemical for organic synthesis and other chemical and pharmaceutical processes.
References Brudeli, B., et al.: Bioorg. Med. Chem., 18, 8600 (2010); Colak, S., et al.: Macromolecules, 41, 8436 (2008)Formule :C8H15BrO2Couleur et forme :NeatMasse moléculaire :223.11(alphaR)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetic Acid Salt
CAS :Produit contrôléApplications Bortezomib (B675700) intermediate. A boronic acid dipeptide derivative as proteasome inhibitors.
References Kisselev, A., et al.: Chem. Biol., 8, 739 (2001), Kisselev, A., et al.: J. Biol. Chem., 278, 35869 (2003), Verdoes, M., et al.: Chem. Biol., 13, 1217 (2006),Formule :C15H28BNO2·C2HF3O2Couleur et forme :NeatMasse moléculaire :379.22N-(1-Carboxy-3-phenylpropyl)-S-lisinopril (Mixture of diastereomers)
CAS :Produit contrôléApplications N-(1-Carboxy-3-phenylpropyl)-S-lisinopril (Mixture of diastereomers) is an impurity of lisinopril (L468985), an orally active angiotensin-converting enzyme (ACE) inhibitor.
References Shinde, V., et. al.: J. Pharm. Biomed. Anal., 43, 381 (2007); Goa, K.L., et al.: Drugs, 52, 564 (1996), Chaturvedi, N., et al.: Lancet, 351, 28 (1998)Formule :C31H41N3O7Couleur et forme :NeatMasse moléculaire :567.679-(2,5-d|-Dioxo-L-3-amino-1-pyrrolidineacetic acid)-10-deglycine Daptomycin
CAS :Produit contrôléApplications 9-(2,5-d|Dioxo-L-3-amino-1-pyrrolidineacetic acid)-10-deglycine Daptomycin is a stereoisomer of Daptomycin (D193350), cyclic lipopeptide antibiotic derived from a fermentation product of Streptomyces roseosporus; disrupts plasma membrane function in gram-positive bacteria. Antibacterial.
References Allen, N.E., et al.: Antimicrob. Agents Chemother., 31, 1093 (1987), Tully, F.P., et al.: Expert Opin. Invest. Drugs, 8, 1223 (1999),Formule :C72H99N17O25Couleur et forme :NeatMasse moléculaire :1602.66(D-His2)-Leuprolide Trifluoroacetic Acid Salt
CAS :Produit contrôléImpurity Leuprolide Acetate EP Impurity B TFA salt
Applications Synthetic nonapeptide agonist analog of LH-RH. Antineoplastic (hormonal).
References Vilchez-Martinez, J.A., et al.: Biochem. Biophys. Res. Commun., 59, 1226 (1974), Sennello, L.T., et al.: J. Pharm. Sci., et al.: 75, 158 (1986), Wheeler, J.M., et al.: Am.J. Obstet. Gynecol., 167, 1367 (1992), Eri, L.M., et al.: J. Urol., 150, 359 (1993),Formule :C59H84N16O12·x(C2HF3O2)Couleur et forme :NeatMasse moléculaire :1209.398(AlphaS)-3-[2-(2,6-Dimethylphenoxy)acetyl]-N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-Alpha-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide
CAS :Produit contrôléImpurity Lopinavir EP Impurity R
Applications (αS)-3-[2-(2,6-Dimethylphenoxy)acetyl]-N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-α-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide (Lopinavir EP Impurity R) is an impurity of Lopinavir (L469480), a selective HIV protease inhibitor.
References Chitturi, S.R., et al.: J. Pharma. Biomed. Anal., 48, 1430 (2008); Devi, A.S.L., et al.: Magnet. Reson. Chem., 45, 424 (2007);Formule :C47H58N4O7Couleur et forme :NeatMasse moléculaire :791.0Deschloro-4’-chloro Clomiphene Hydrochloride
CAS :Produit contrôléApplications An impurity of Clomiphene (C587025).
Formule :C26H29Cl2NOCouleur et forme :NeatMasse moléculaire :442.423,5,3',5'-Tetraiodo Thyroaldehyde
CAS :Produit contrôléImpurity Levothyroxine EP Impurity I; T4-Aldehyde (USP)
Applications 3,5,3',5'-Tetraiodo Thyroaldehyde (Levothyroxine EP Impurity I; T4-Aldehyde (USP)) is a Thyroid hormone analogue and a Thyroxine (T425600) analogue.
References Horst, C., et al.: Biochem. J., 261, 945 (1989), Kvetny, J., et al.: Horm. Metab. Res., 24, 322 (1992), Yamauchi, K., et al.: J. Biol. Chem., 274, 8460 (1999), Davis, P., et al.: J. Endocrinol. Invest., 25, 377 (2002),Formule :C13H6I4O3Couleur et forme :Light Beige To BrownMasse moléculaire :717.8Lopinavir Metabolite M-3/M-4
CAS :Produit contrôléApplications A major metabolite of Lopinavir (L469480) . It is a COVID19-related research product.
References Molla, A., et al.: J. Virology, 250, 255 (1998), Sham, H., et al.: Antimicrob. Agents Chemother., 42, 3218 (1998), Kumar, G., et al.: Drug Metab. Dispos., 27, 86 (1999),Formule :C37H48N4O6Couleur et forme :NeatMasse moléculaire :644.8(S)-N-[1-(3-Hydroxy-3-methylbutanamido)-1-oxo-3-phenylpropan-2yl]pyrazine-2-carboxamide
Produit contrôléFormule :C19H22N4O4Couleur et forme :NeatMasse moléculaire :370.4Lysipressin Acetic Acid Salt
CAS :Applications Lysipressin Acetic Acid Salt, is an analog of Vasopressin (A769550), a powerful vasopressor used to modulate blood pressure. An endogenous antidiuretic hormone in most mammalian species. It is released into the blood from nerve terminals in the posterior pituitary and median eminence. It is a neurotransmitter in the central nervous system and also implicated in a variety of physiological processes such as regulating water balance by antidiuretic action.
References Yamashita, K. et al.: Mol. Phylo., 67, 520 (2013); Hua F. et al.: J. Emerg. Med., 44, 434 (2013); Perucca, J. et al.: J. AM. Soc. Nephrol., 19, 1721 (2008); Toba, K. et al.: Prog. Brain Res., 119, 337 (1998); Berrada, K. et al.: J. Biol. Chem., 275, 27229 (2000);Formule :C46H65N13O12S2·xC2H4O2Couleur et forme :White SolidMasse moléculaire :1116.3(2S)-1-Nitrosopyrrolidine-2-carboxamide
CAS :Produit contrôléFormule :C5H9N3O2Couleur et forme :NeatMasse moléculaire :143.14Boceprevir-d9
CAS :Produit contrôléApplications A labelled NS3 serine protease inhibitor of hepatitis C virus. It is a COVID19-related research product.
References Malcolm, B., et al.: Antimicrob. Agents Chemother., 50, 1013 (2006); Cubero, M., et al.: Virology, 370, 237 (2008); Venkatraman, S., et al.: J. Med. Chem., 49, 6074 (2006);Formule :C272H9H36N5O5Couleur et forme :NeatMasse moléculaire :528.73(R)-3-Carboxy-2-hydroxy-N,N,N-trimethylpropan-1-aminium Chloride
CAS :Produit contrôléStability Hygroscopic
Applications (R)-3-Carboxy-2-hydroxy-N,N,N-trimethylpropan-1-aminium chloride is an important co-factor of mammalian mitochondrial energy metabolism. It is also a good active ingredient for dry-skin.
References Geier, David A., et al.: Neurochem. Res., 38(11), 2336-2341 (2013);Tanno, Osamu, et al.: Fragrance J., 33(8), 82-85 (2005);Formule :C7H16NO3·ClCouleur et forme :White To Off-WhiteMasse moléculaire :197.66(S)-4-Oxo-homophenylalanine Hydrochloride
CAS :Produit contrôléStability Hygroscopic
Applications (S)-4-Oxo-homophenylalanine Hydrochloride is a derivative of L-Homophenylalanine (H600500); an antitumor agent.
References Brunner, Henri., et al.: Eur. J. Med. Chem., 25, 35 (1990)Formule :C10H12ClNO3Couleur et forme :NeatMasse moléculaire :229.66(alphaS)-α-Amino-N-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]-benzenepropanamide Monohydrochloride
CAS :Produit contrôléApplications (αS)-α-Amino-N-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]-benzenepropanamide Monohydrochloride is a Bortezomib (B675700) intermediate which is used in the evaluation of bone-targeted proteasome inhibitors for myeloma.
References Agyin, J.K., et al.: Bioorg. Med. Chem. Lett., 23, 6455 (2013); Traenckner, E., et al.: EMBO. J., 13, 5433 (1994)Formule :C24H37BN2O3·ClHCouleur et forme :NeatMasse moléculaire :448.83411-Nitrosopyrrolidine-2-carboxylic Acid
CAS :Produit contrôléApplications 1-nitrosopyrrolidine-2-carboxylic acid (cas# 2571-28-0) is a useful research chemical.
Formule :C5H8N2O3Couleur et forme :NeatMasse moléculaire :144.129(S,S)-Hydroperoxy Des(boric Acid) Bortezomib
CAS :Produit contrôléImpurity Bortezomib USP Impurity L
Stability Unstable in Methanol
Applications (R)-Hydroperoxy Des(boric Acid) Bortezomib is an impurity of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer.
References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009);Formule :C19H24N4O4Couleur et forme :White To Off-WhiteMasse moléculaire :372.423,5,3',5'-Tetraiodo Thyroacetamide
CAS :Produit contrôléImpurity Levothyroxine Acetamide Impurity
Applications 3,5,3',5'-Tetraiodo Thyroacetamide is a thyroid hormone analogue, a Thyroxine (T425600) impurity.
References Andre, M., et al.: J. Chromatogr., 741, 146 (1996),Formule :C14H9I4NO3Couleur et forme :Light Orange Colour To Light BrownMasse moléculaire :746.84N-[(1S)-2-[(3-Methylbutyl)amino]-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide
CAS :Produit contrôléFormule :C19H24N4O2Couleur et forme :White To Off-WhiteMasse moléculaire :340.4195(S)-2-((S)-4-Methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoic Acid
CAS :Produit contrôléApplications (S)-2-((S)-4-Methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoic Acid is an intermediate for Carfilzomib (C183460), which is a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma.
References Fostier, K., et al.: Oncotargets. Therap., 5, 237 (2012); Geurink, P.P., et al.: J. Med. Chem., 56, 1262 (2013); McCormack, P.L., et al.: Drugs., 72, 2023 (2012);Formule :C31H42N4O6Couleur et forme :NeatMasse moléculaire :566.695-Oxo-L-proline-d5
CAS :Produit contrôléApplications 5-Oxo-L-proline-d5 is a labelled cyclized derivative of L-Glutamic Acid (G596960). The pyroglutamate core has potential application for synthesis of novel anti-bacterials.
References Mischo A. et al.: ChemBioChem., 13, 1421 (2012); Angelov P. et al.: Org. Biomol. Chem.: 10, 3472 (2012);Formule :C5D5H2NO3Couleur et forme :White To Off-WhiteMasse moléculaire :134.14Daptomycin Impurity B1-I
Applications Daptomycin Impurity B1-1 is an impurity of Daptomycin (D193350), cyclic lipopeptide antibiotic derived from a fermentation product of Streptomyces roseosporus; disrupts plasma membrane function in gram-positive bacteria. Antibacterial.
References Allen, N.E., et al.: Antimicrob. Agents Chemother., 31, 1093 (1987), Tully, F.P., et al.: Expert Opin. Invest. Drugs, 8, 1223 (1999),Formule :C44H66N10O15•(C2HF3O2)Couleur et forme :Off White SolidMasse moléculaire :975.0511402(S)-Hydroxy Des(boric Acid) Bortezomib
CAS :Produit contrôléImpurity Bortezomib USP Impurity J
Applications (S)-Hydroxy Des(boric Acid) Bortezomib is an impurity in the synthesis of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.
References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl, C. et al.: Chem. and Eng. News, 87, 41 (2009)Formule :C19H24N4O3Couleur et forme :NeatMasse moléculaire :356.42N1.9,N1.9-Dimethyldesmopressin
N1.9,N1.9-Dimethyldesmopressin is a synthetic analog of the natural hormone vasopressin. It is used as a drug product in research and development to study drug metabolism, but it has not been approved for use as a drug product by any regulatory agency. Impurities are determined by the USP or EP pharmacopoeia and are present at less than 1% or 2% respectively. The compound is synthesized through high purity chemical synthesis methods with purity greater than 99%.Degré de pureté :Min. 95%[9-Glycine]desmopressin
9-Glycine Desmopressin is a drug product that has been custom synthesized for use in research and development. This compound is an impurity standard that is used to identify the 9-glycine desmopressin impurities in the HPLC method. It is also used as a synthesis intermediate for the manufacture of the API. The CAS number for this compound is [CAS NO.]. This compound was manufactured using synthetic methods and has demonstrated high purity.Degré de pureté :Min. 95%Lisinopril diketopipirazine
CAS :Lisinopril diketopipirazine is an analytical drug product. The CAS number for this product is 219677-82-4. This product requires a custom synthesis and impurity standard. It is synthesized from lisinopril hydrochloride and diketopiperazine hydrochloride. Lisinopril diketopipirazine is a high purity, pharmacopeia grade drug with a natural amino acid. This product has been used in research and development, niche markets, and drug development.Formule :C21H29N3O4Degré de pureté :90%MinCouleur et forme :White To Off-White SolidMasse moléculaire :387.47 g/molLevothyroxine EP impurity B
CAS :Please enquire for more information about Levothyroxine EP impurity B including the price, delivery time and more detailed product information at the technical inquiry form on this pageFormule :C15H11ClI3NO4Degré de pureté :Min. 95%Masse moléculaire :685.42 g/mol(R)-3-((R)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid
CAS :(R)-3-((R)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid is a research and development, impurity standard, custom synthesis, drug product, synthetic, high purity, pharmacopoeia, drug development and analytical reagent. CAS No. 162148-17-6Formule :C9H12N2O4SDegré de pureté :Min. 95%Masse moléculaire :244.27 g/molLevothyroxine lactose adduct
Levothyroxine is a drug product that is used for the treatment of hypothyroidism. It is an analog of thyroxine, which is synthesized in the thyroid gland. Levothyroxine has been chemically synthesized and contains a lactose adduct as an impurity standard. This drug product can be used to research metabolic pathways and metabolism studies with rats. Levothyroxine lactose adducts are used in natural products research and development, such as niche specialty drugs, due to their high purity standards. The CAS number for Levothyroxine lactose adduct is 266-072-3.Formule :C27H31I4NO14Degré de pureté :85%MinMasse moléculaire :1,101.15 g/mol[4-L-Glutamic Acid]-desmopressin
4-L-Glutamic Acid]-desmopressin is an analytical standard that is used to calibrate HPLC systems. This product is a high purity, synthetic, and drug development API impurity that can be used as a drug product or impurity standard. It is also available as an HPLC standard, niche, and custom synthesis. 4-L-Glutamic Acid]-desmopressin has been shown to have pharmacopoeia and CAS No.Degré de pureté :Min. 95%(5aR,10aR)-Tetrahydro-3H,5H,8H,10H-bisthiazolo[3,4-a:3',4'-d]pyrazine-5,10-dione
CAS :(5aR,10aR)-Tetrahydro-3H,5H,8H,10H-bisthiazolo[3,4-a:3',4'-d]pyrazine-5,10-dione is a drug product that is an impurity standard for the API (Active Pharmaceutical Ingredient) 5α-tetrahydrospiro[benzofuran-1(3H),2'(3'H)]pyrido-[2,1'-cyclohexan]-6β,7β-(1'H)-dione. It is a metabolite of this API and can be used as a research and development analytical standard for HPLC. The CAS number for this compound is 72744-67-3. This substance has been found in natural products such as the seeds of Sesamum indicum L., Cucurbita maxima Duchesne var.Formule :C8H10N2O42S2Degré de pureté :Min. 95%Masse moléculaire :870.29 g/molL-803087
CAS :L-803087: potent sst4 receptor agonist, 0.7 nM Ki, 280x selectivity, boosts AMPA responses & seizures in mice.Formule :C25H29F2N5O3Degré de pureté :99.37%Couleur et forme :SolidMasse moléculaire :485.53Ref: TM-T11800
1mg50,00€5mg112,00€1mL*10mM (DMSO)126,00€10mg175,00€25mg366,00€50mg585,00€100mg928,00€200mg1.234,00€(1S,2S)-Bortezomib
CAS :(1S,2S)-Bortezomib (Bortezomib) is an enantiomer of Bortezomib.Formule :C19H25BN4O4Degré de pureté :99.6%Couleur et forme :SolidMasse moléculaire :384.24Ref: TM-T10061
1mg60,00€2mg92,00€5mg160,00€1mL*10mM (DMSO)163,00€10mg269,00€25mg429,00€50mg583,00€100mg783,00€Cetrorelix Acetate
CAS :Cetrorelix Acetate is gonadotropin-releasing hormone (GnRH) receptor antagonist with an IC50 of 1.21 nM.Formule :C70H92ClN17O14·xC2H4O2Degré de pureté :97.96%Couleur et forme :SolidMasse moléculaire :1491.11Felypressin acetate
CAS :Felypressin acetate (PLV-2) is an agonist of vasopressin 1 and acts on all arginine vasopressin receptors 1AS.Formule :C48H69N13O13S2Degré de pureté :97.06%Couleur et forme :SolidMasse moléculaire :1100.27MEDICA16
CAS :MEDICA16: GPR40 agonist, GPR120 partial agonist, ATP-citrate lyase inhibitor, lowers TG, boosts insulin sensitivity in muscle.Formule :C20H38O4Degré de pureté :99.62% - 99.87%Couleur et forme :White SolidMasse moléculaire :342.51Ref: TM-T22967
5mg60,00€1mL*10mM (DMSO)80,00€10mg92,00€25mg168,00€50mg289,00€100mg419,00€500mg874,00€D-Ile-23-semaglutide trifluoroacetate
D-Ile(23)-Semaglutide trifluoroacetate is a semaglutide impurity. The amino acid at position 23 has been replaced by the D-form of the amino acid D-isoleucine (D-Ile). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Degré de pureté :Min. 95%(5aS,10aS)-Tetrahydrodipyrrolo[1,2-a:1',2'-d]pyrazine-3,5,8,10(2H,5aH)-tetraone
CAS :The objective of this project is to design a microcontroller-based system that can monitor and diagnose the level of damage in a composite material. The system will consist of an array of sensors, actuators, and microcontrollers that are connected by a wireless network. The sensors will measure the levels of damage at each point within the composite material. The actuators will provide feedback to the sensors, adjusting their frequency and amplitude based on the level of damage detected. Microcontrollers will be responsible for analyzing data from the sensors and diagnosing any faults in the system. A miniaturized dry skin patch could be used as an alternative to traditional wet skin tests for monitoring skin health.Formule :C10H10N2O4Degré de pureté :Min. 95%Masse moléculaire :222.2 g/molLRK-4189
CAS :LRK-4189, Oral PIP4K2C PROTAC degrader (DC50 <500 nM), induces apoptosis, activates interferon pathway, for MSS colorectal cancer (CRC).Formule :C43H49F2N9O4Couleur et forme :SolidMasse moléculaire :793.9Duostatin 5
CAS :Duostatin 5 (Duo-5) is a sea hare toxin analog commonly used in the synthesis of ADC compounds.Formule :C40H69N9O6Degré de pureté :96.98%Couleur et forme :SolidMasse moléculaire :772.03Ref: TM-T77841
1mg54,00€5mg114,00€1mL*10mM (DMSO)142,00€10mg167,00€25mg313,00€50mg528,00€100mg848,00€AZD-1656
CAS :AZD-1656 is a glucokinase activator (GKA) that can cause dose-limiting hypoglycemia in normal animals used in embryofetal development studies and type 2Formule :C24H26N6O5Degré de pureté :97.07% - 99.37%Couleur et forme :SolidMasse moléculaire :478.5STAT3 degrader-2
CAS :STAT3 Degrader-2 is a PROTAC-based compound that effectively reduces the total STAT3 protein levels, and is utilized in the research of cancer and variousFormule :C59H62N9O13PDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :1136.15CG 428
CAS :CG 428 is a potent tropomyosin receptor Kinase (TRK) Degrader (uSMITETM) with a DC50 of 0.36 nM.Formule :C43H43FN10O6Degré de pureté :99.86%Couleur et forme :SolidMasse moléculaire :814.86Ref: TM-T41224
1mg166,00€5mg400,00€1mL*10mM (DMSO)414,00€10mg590,00€25mg888,00€50mg1.243,00€100mg1.693,00€500mg3.402,00€C004019
CAS :C004019 is a small molecule PROTAC capable of targeting tau for selective protein degradation from the cell, while recruiting tau and E3 ligase (Vhl) for
Formule :C49H70N12O9S2Degré de pureté :99.89%Couleur et forme :SoildMasse moléculaire :1035.29Pidotimod diketopiperazine-6-propanoic acid
CAS :Pidotimod is an impurity in the drug product, which is a synthetic diketopiperazine-6-propanoic acid. Pidotimod is an impurity standard that is used in the development of drugs and as a pharmacopoeia. It has been shown to be metabolized by human liver microsomes and human erythrocytes.Formule :C9H12N2O4SDegré de pureté :Min. 95%Masse moléculaire :244.27 g/molLGD-6972
CAS :LGD-6972 is an antagonist of glucagon receptor.Formule :C43H46N2O5SDegré de pureté :98.8% - 99.62%Couleur et forme :SolidMasse moléculaire :702.9Ref: TM-T11845
1mg84,00€5mg177,00€10mg260,00€1mL*10mM (DMSO)268,00€25mg447,00€50mg655,00€100mg888,00€Reldesemtiv
CAS :Reldesemtiv (CK-2127107) boosts exercise capacity, targeting fast muscle troponin, EC50 3.4 μM.Formule :C19H18F2N6ODegré de pureté :97.27%Couleur et forme :SolidMasse moléculaire :384.38XY028-140
CAS :XY028-140 is a selective CDK4/6 inhibitor and degrader, acting via PROTAC with ligands for Cereblon and CDK in cancer cells.Formule :C39H40N10O7Degré de pureté :98.59%Couleur et forme :SolidMasse moléculaire :760.8AMG 837 calcium hydrate
CAS :AMG 837 calcium hydrate is a potent GPR40 agonist with an EC50 of 13 nM.Formule :C52H44CaF6O8Degré de pureté :98.07%Couleur et forme :SolidMasse moléculaire :950.97L-796778 acetate
CAS :L-796778 acetate is a selective sst3 receptor agonist. In CHO-K1 cells expressing hsst3 receptors, it acts as a partial agonist that inhibits Forskolin-induced cAMP production, with an IC50 value of 18 nM. Additionally, L-796778 acetate exhibits anticonvulsant properties.Formule :C31H44N6O9Couleur et forme :SolidMasse moléculaire :644.716(2S,4S)-Sacubitril
CAS :(2S,4S)-Sacubitril (Sacubitril Impurity C) is a stereoisomer derived from Sacubitril which is a potent NEP inhibitor.Formule :C24H29NO5Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :411.49Tabimorelin hemifumarate
CAS :orally active ghrelin receptor (GHS-R1a) agonistFormule :C32H40N403C4H404Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :586.72Pateamine A
CAS :Pateamine A: marine-sourced macrolide from Mycale hentscheli; anticancer, antiviral, and translation inhibitor.Formule :C31H45N3O4SCouleur et forme :SolidMasse moléculaire :555.77PIN1 ligand-2
CAS :PIN1ligand-2 (Intermediate M6) is a ligand designed for PROTAC target proteins (Ligands for Target Protein for s). It can be utilized in the synthesis of PROTACT(Rac)-P1D-34.Formule :C15H25ClN2O6SCouleur et forme :SolidMasse moléculaire :396.887SSTR4 agonist 5
CAS :SSTR4 agonist5 (Compound 5) is an orally active agonist of the somatostatin receptor 4 (SSTR4) with an EC50 of 0.228 nM. It demonstrates good stability in human/rat liver microsomes and can inhibit mechanical hyperalgesia in rat models.Formule :C20H26N4OMasse moléculaire :338.447Marizomib
CAS :Marizomib is a novel irreversible brain-permeable proteasome inhibitor that inhibits CT-L, CT-T-laspase-like, and trypsin-like 20S proteasomes.Cost-effective and quality-assured.Formule :C15H20ClNO4Degré de pureté :98.03% - 99.41%Couleur et forme :SolidMasse moléculaire :313.78(S)-dHTC1
CAS :(S)-dHTC1 is a molecular glue degrader specifically targeting the transcriptional coactivator ENL. It exhibits high affinity binding to E3 ligase only upon formation of the ENL:(S)-dHTC1 complex, with an IC50 of 93 nM. In MV4;11 cells, (S)-dHTC1 degrades ENL with a DC50 of 26 nM. This compound can be utilized for acute myeloid leukemia research.Formule :C33H40N8O6SCouleur et forme :SolidMasse moléculaire :676.786SST1 receptor antagonist-1
CAS :SST1 receptor antagonist-1 (Compound 23) is a selective antagonist of the somatostatin receptor 1 (SST1), showing a pKd of 9.11 for rSST1 and 8.79 for hSST1. This compound is applicable in research related to retinal and endocrine dysfunction, cancer, and neuropsychiatric disorders.Formule :C29H31F2N3O2Couleur et forme :SolidMasse moléculaire :491.57FK-565
CAS :FK-565 is a ligand of nucleotide-binding oligomerization domain-1 (NOD1) that induces a mouse model of arteritis.Formule :C22H38N4O9Couleur et forme :SolidMasse moléculaire :502.559SSTR5 antagonist 6
CAS :SSTR5 antagonist 6, an orally active antagonist specific to the somatostatin receptor subtype 5 (SSTR5), exhibits an IC50 value of 24 nM. This compound is utilized in researching type 2 diabetes [1].Formule :C22H28ClN3O4Couleur et forme :SolidMasse moléculaire :433.93[D-His]-Leuprolide (5-Oxo-L-prolyl-D-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide)
CAS :Lactams, nesoiFormule :C59H84N16O12Couleur et forme :Off-White PowderMasse moléculaire :1208.64546[MetO8]-Teriparatide
Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormule :C181H291N55O52S2Couleur et forme :Off-White PowderMasse moléculaire :4131.12586Isocyclosporin A
CAS :Lactams, nesoiFormule :C62H111N11O12Couleur et forme :White Off-White PowderMasse moléculaire :1201.84137[MetO8,18]-Teriparatide
CAS :Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormule :C181H291N55O53S2Couleur et forme :Off-White SolidMasse moléculaire :4147.12077[Lys(Ac)]5-Octreotide (D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-N6-acetyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide cyclic (2-->7)-disulfide)
CAS :Polypeptide, protein and glycoprotein hormones, their derivatives and structural analogues, nesoiFormule :C51H68N10O11S2Couleur et forme :Off-White PowderMasse moléculaire :1060.45105Insulin Human (COLD SHIPMENT REQUIRED) (DISCONTINUED)
CAS :Insulin and its saltsFormule :C257H383N65O77S6Couleur et forme :White CrystalsMasse moléculaire :5803.63765




